Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases

Lung Cancer

Volumn 77, Issue 2, 2012, Pages 389-393

  Guo, Susan ^a   Reddy, Chandana A ^a   Chao, Samuel T ^a,b   Suh, John H ^a,b   Barnett, Gene H ^a,b   Vogelbaum, Michael A ^a,b   Videtic, Gregory M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Rose Ella Burkhardt Brain Tumor and Neuro Oncology Center   (United States)

Author keywords

Brain metastases; Graded prognostic assessment; Histology; Non small cell lung cancer; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CALCULATION; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; FEMALE; GRADED PROGNOSTIC ASSESSMENT; HISTOLOGY; HUMAN; KARNOFSKY PERFORMANCE STATUS; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REFERENCE DATABASE; STATISTICAL SIGNIFICANCE; SURVIVAL PREDICTION; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 84863774618     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.03.028     Document Type: Article

References (21)

1. Nussbaum E.S., Djalilian H.R., Cho K.H., Hall W.A. Brain metastases, histology, multiplicity, surgery, and survival. Cancer 1996, 78:1781-1788.
2. Chang J.E., Robins H.I., Mehta M.P. Therapeutic advances in the treatment of brain metastases. Clin Adv Hematol Oncol 2007, 5:54-64.
3. Suh J.H. Stereotactic radiosurgery for the management of brain metastases. N Engl J Med 2010, 362:1119-1127.
4. Lorenzoni J., Devriendt D., Massager N., David P., Ruiz S., Vanderlinden B., et al. Radiosurgery for treatment of brain metastases: estimation of patient eligibility using three stratification systems. Int J Radiat Oncol Biol Phys 2004, 60:218-224.
5. Gaspar L., Scott C., Rotman M., Asbell S., Phillips T., Wasserman T., et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 1997, 37:745-751.
6. Weltman E., Salvajoli J.V., Brandt R.A., de Morais Hanriot R., Prisco F.E., Cruz J.C., et al. Radiosurgery for brain metastases: a score index for predicting prognosis. Int J Radiat Oncol Biol Phys 2000, 46:1155-1161.
7. Sperduto P.W., Berkey B., Gaspar L.E., Mehta M., Curran W. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 2008, 70:510-514.
8. Mehta M.P., Rodrigus P., Terhaard C.H., Rao A., Suh J., Roa W., et al. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol 2003, 21:2529-2536.
9. Scagliotti G.V., Parikh P., von Pawel J., Biesma B., Vansteenkiste J., Manegold C., et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008, 26:3543-3551.
10. Cannady S.B., Cavanaugh K.A., Lee S.Y., Bukowski R.M., Olencki T.E., Stevens G.H., et al. Results of whole brain radiotherapy and recursive partitioning analysis in patients with brain metastases from renal cell carcinoma: a retrospective study. Int J Radiat Oncol Biol Phys 2004, 58:253-258.
11. Andrews D.W., Scott C.B., Sperduto P.W., Flanders A.E., Gaspar L.E., Schell M.C., et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
12. Bajard A., Westeel V., Dubiez A., Jacoulet P., Pernet D., Dalphin J.C., et al. Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinoma. Lung Cancer 2004, 45:317-323.
13. Strauss B., Weller C.V. Bronchogenic carcinoma; a statistical analysis of two hundred ninety-six cases with necropsy as to relationships between cell types and age, sex, and metastasis. AMA Arch Pathol 1957, 63:602-611.
14. Figlin R.A., Piantadosi S., Feld R. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small-cell lung cancer. N Engl J Med 1988, 318:1300-1305.
15. Mujoomdar A., Austin J.H., Malhotra R., Powell C.A., Pearson G.D., Shiau M.C., et al. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. Radiology 2007, 242:882-888.
16. Schiller J.H., Harrington D., Belani C.P., Langer C., Sandler A., Krook J., et al. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002, 346:92-98.
17. Sperduto C.M., Watanabe Y., Mullan J., Hood T., Dyste G., Watts C., et al. A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment. J Neurosurg 2008, 109(Suppl.):87-89.
18. Sperduto P.W., Chao S.T., Sneed P.K., Luo X., Suh J., Roberge D., et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 2010, 77:655-661.
19. Nieder C., Marienhagen K., Geinitz H., Molls M. Validation of the graded prognostic assessment index for patients with brain metastases. Acta Oncol 2009, 48:457-459.
20. Nieder C., Geinitz H., Molls M. Validation of the graded prognostic assessment index for surgically treated patients with brain metastases. Anticancer Res 2008, 28:3015-3017.
21. Nieder C., Bremnes R.M., Andratschke N.H. Prognostic scores in patients with brain metastases from non-small cell lung cancer. J Thorac Oncol 2009, 4:1337-1341.